280 related articles for article (PubMed ID: 18348910)
1. How free of residual cells and cell antigens is human blood plasma? A comparison of different production methods of human blood plasma and the risk of the products for patients.
Wurm K; Rummler S; Barz D
Transfus Apher Sci; 2008 Apr; 38(2):149-57. PubMed ID: 18348910
[TBL] [Abstract][Full Text] [Related]
2. Separation of whole blood into plasma and red cells by using a hollow-fibre filtration system.
Hornsey VS; McColl K; Drummond O; Prowse CV
Vox Sang; 2005 Aug; 89(2):81-5. PubMed ID: 16101688
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte depletion for safe blood transfusion.
Singh S; Kumar A
Biotechnol J; 2009 Aug; 4(8):1140-51. PubMed ID: 19418471
[TBL] [Abstract][Full Text] [Related]
4. [Detection of antigen structures in blood cells in various prepared plasma transfusions].
Barz D
Anaesthesiol Reanim; 1994; 19(6):155-8. PubMed ID: 7532411
[TBL] [Abstract][Full Text] [Related]
5. Whole blood leukocytes isolation with microfabricated filter for cell analysis.
Yu L; Warner P; Warner B; Recktenwald D; Yamanishi D; Guia A; Ghetti A
Cytometry A; 2011 Dec; 79(12):1009-15. PubMed ID: 22110022
[TBL] [Abstract][Full Text] [Related]
6. Quality of plasma separated from (buffy coat + plasma). An alternative way of blood processing.
Rácz Z; Baróti C; Hidvégi T; Skopál J; Thék M
Acta Haematol Pol; 1994; 25(1):47-53. PubMed ID: 8209614
[TBL] [Abstract][Full Text] [Related]
7. Production of leucocyte poor blood. A comparison of five different methods.
Grunnet N; Rasmussen NJ
Scand J Urol Nephrol Suppl; 1981; 64():106-11. PubMed ID: 6959257
[TBL] [Abstract][Full Text] [Related]
8. Correction of hyperviscosity by apheresis.
Zarkovic M; Kwaan HC
Semin Thromb Hemost; 2003 Oct; 29(5):535-42. PubMed ID: 14631553
[TBL] [Abstract][Full Text] [Related]
9. Leukocyte-poor blood.
Wenz B
Crit Rev Clin Lab Sci; 1986; 24(1):1-20. PubMed ID: 3539518
[TBL] [Abstract][Full Text] [Related]
10. Clinical effects of different types of red cell concentrates in patients with thalassemia and sickle cell disease.
Cabibbo S; Fidone C; Antolino A; Manenti OG; Garozzo G; Travali S; Bennardello F; Di Stefano R; Bonomo P
Transfus Clin Biol; 2007 Dec; 14(6):542-50. PubMed ID: 18434227
[TBL] [Abstract][Full Text] [Related]
11. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production.
Levin E; Culibrk B; Gyöngyössy-Issa MI; Weiss S; Scammell K; LeFresne W; Jenkins C; Devine DV
Transfusion; 2008 Nov; 48(11):2331-7. PubMed ID: 18631169
[TBL] [Abstract][Full Text] [Related]
12. [Effectiveness of different methods of blood separation in performing plasma- and cytapheresis].
Ryzhko VV; Gorodetskiĭ VM; Rogova EM
Ter Arkh; 1988; 60(5):85-8. PubMed ID: 3175936
[TBL] [Abstract][Full Text] [Related]
13. Preparation of blood products for transfusion: is there a best method?
Devine DV; Serrano K
Biologicals; 2012 May; 40(3):187-90. PubMed ID: 22119012
[TBL] [Abstract][Full Text] [Related]
14. Successful removal of Chlamydia pneumoniae from plateletpheresis products collected using automated leukoreduction hemapheresis techniques.
Webley W; Stuart E; Cirino F; Cahill F; Stec T; Andrzejewski C
J Clin Apher; 2006 Oct; 21(3):195-201. PubMed ID: 16570261
[TBL] [Abstract][Full Text] [Related]
15. Markers of platelet activation and apoptosis in platelet concentrates collected by apheresis.
Procházková R; Andrýs C; Hubácková L; Krejsek J
Transfus Apher Sci; 2007 Oct; 37(2):115-23. PubMed ID: 17945536
[TBL] [Abstract][Full Text] [Related]
16. Quo vadis haemapheresis. Current developments in haemapheresis.
Borberg H
Transfus Apher Sci; 2006 Feb; 34(1):51-73. PubMed ID: 16412691
[TBL] [Abstract][Full Text] [Related]
17. Discarded cellular components and the technical efficiency of component preparation.
Veihola M; Aroviita P; Kekomäki R; Linna M; Sintonen H
Eur J Health Econ; 2008 Nov; 9(4):325-31. PubMed ID: 17962987
[TBL] [Abstract][Full Text] [Related]
18. Facilitating blood component preparation: the impact of overnight room temperature storage.
McLaughlin LS; Moroff G; Benjamin RJ
Transfusion; 2010 Feb; 50(2):278-80. PubMed ID: 20088837
[No Abstract] [Full Text] [Related]
19. Pathogen reduction of blood components.
Solheim BG
Transfus Apher Sci; 2008 Aug; 39(1):75-82. PubMed ID: 18602343
[TBL] [Abstract][Full Text] [Related]
20. [Neocytapheresis in donors].
Kalinin NN; Varlamova SV; Pashinin AN; Petrov MM; Cherstvova LG; Ostrovskaia EE; Batashova TV
Sov Med; 1991; (5):41-3. PubMed ID: 1876920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
